Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bioceres Crop Solutions (BIOX) Shares Outstanding (Weighted Average) (2016 - 2026)

Bioceres Crop Solutions' Shares Outstanding (Weighted Average) history spans 11 years, with the latest figure at $63.6 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 1.27% to $63.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $63.6 million, a 1.27% increase, with the full-year FY2025 number at $63.2 million, up 0.62% from a year prior.
  • Shares Outstanding (Weighted Average) hit $63.6 million in Q1 2026 for Bioceres Crop Solutions, up from $63.2 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for BIOX hit a ceiling of $63.6 million in Q1 2026 and a floor of $42.3 million in Q2 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $59.5 million across 5 years, with a median of $62.8 million in 2024.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): skyrocketed 46.91% in 2023 and later grew 0.62% in 2025.
  • Tracing BIOX's Shares Outstanding (Weighted Average) over 5 years: stood at $42.3 million in 2022, then skyrocketed by 46.91% to $62.1 million in 2023, then rose by 1.12% to $62.8 million in 2024, then rose by 0.62% to $63.2 million in 2025, then rose by 0.59% to $63.6 million in 2026.
  • Business Quant data shows Shares Outstanding (Weighted Average) for BIOX at $63.6 million in Q1 2026, $63.2 million in Q2 2025, and $62.8 million in Q1 2025.